Frequent somatic mutations of the transcription factor ATBF1 in human prostate cancer

Xiaodong Sun1, Henry F Frierson, Ceshi Chen

  • 1Winship Cancer Institute, Department of Hematology and Oncology, Emory University School of Medicine, Atlanta, Georgia 30322, USA.

Nature Genetics
|March 8, 2005
PubMed

Insights

The AT-binding factor 1 (ATBF1) gene, located on chromosome 16q22, is frequently altered in prostate cancer. Loss of ATBF1 function contributes to uncontrolled cell growth, identifying it as a potential tumor suppressor.

Area of Science:

  • Genetics
  • Molecular Biology
  • Oncology

Background:

  • Cancer development involves accumulating genetic alterations.
  • The tumor suppressor gene targeted by 16q22 deletions in human cancers remains unidentified.
  • ATBF1 is a transcription factor regulating AFP, MYB, and CDKN1A.

Purpose of the Study:

  • To identify the tumor suppressor gene responsible for 16q22 deletions in human cancers.
  • To investigate the role of ATBF1 in prostate cancer development.

Main Methods:

  • Deletion mapping to narrow down the 16q22 region to 861 kb containing ATBF1.
  • Analysis of ATBF1 mRNA levels in normal and cancerous prostate tissues.
  • Somatic mutation analysis of the ATBF1 gene in prostate cancer samples.
  • Assessment of ATBF1's effect on cell proliferation.

Main Results:

  • ATBF1 was identified as a candidate tumor suppressor gene at 16q22.
  • ATBF1 mRNA levels were reduced in approximately 50% of prostate cancers.
  • 22 unique somatic mutations in ATBF1 were found in 36% of prostate cancers, many impairing its function.
  • ATBF1 demonstrated inhibition of cell proliferation.

Conclusions:

  • Loss of ATBF1 function is a mechanism contributing to uncontrolled cell proliferation in prostate cancer.
  • ATBF1 acts as a tumor suppressor gene at the 16q22 locus.
  • These findings highlight the significance of ATBF1 in prostate tumorigenesis.

Related Concept Videos

Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Transcription Factors02:16

Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...